193 related articles for article (PubMed ID: 28390982)
21. Viral-induced Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplant.
Dosin G; Aoun F; El Rassy E; Assi T; Lewalle P; Blanc J; van Velthoven R; Bron D
Clin Lymphoma Myeloma Leuk; 2017 Jul; 17(7):438-442. PubMed ID: 28559150
[TBL] [Abstract][Full Text] [Related]
22. Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study.
Harrison N; Mitterbauer M; Tobudic S; Kalhs P; Rabitsch W; Greinix H; Burgmann H; Willinger B; Presterl E; Forstner C
BMC Infect Dis; 2015 Dec; 15():584. PubMed ID: 26715563
[TBL] [Abstract][Full Text] [Related]
23. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
Barba P; Piñana JL; Valcárcel D; Querol L; Martino R; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1439-46. PubMed ID: 19822304
[TBL] [Abstract][Full Text] [Related]
24. Outcomes of lung transplantation after allogeneic hematopoietic stem cell transplantation.
Cheng GS; Edelman JD; Madtes DK; Martin PJ; Flowers ME
Biol Blood Marrow Transplant; 2014 Aug; 20(8):1169-75. PubMed ID: 24727334
[TBL] [Abstract][Full Text] [Related]
25. Early and late complications following hematopoietic stem cell transplantation in pediatric patients - A retrospective analysis over 11 years.
Hierlmeier S; Eyrich M; Wölfl M; Schlegel PG; Wiegering V
PLoS One; 2018; 13(10):e0204914. PubMed ID: 30325953
[TBL] [Abstract][Full Text] [Related]
26. Epileptic seizures in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors, and survival rates.
Zhang XH; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Fu HX; Liu KY; Huang XJ
Clin Transplant; 2013; 27(1):80-9. PubMed ID: 22938074
[TBL] [Abstract][Full Text] [Related]
27. Clinical performance of metagenomic next-generation sequencing for diagnosis of invasive fungal disease after hematopoietic cell transplant.
Zhang X; Zhang L; Li Y; Wang N; Zhang Y
Front Cell Infect Microbiol; 2024; 14():1210857. PubMed ID: 38590441
[TBL] [Abstract][Full Text] [Related]
28. Neurological Complications Involving the Central Nervous System After Allogeneic Hematopoietic Stem Cell Transplantation During a Period of Evolution in Transplant Modalities: A Cohort Analysis.
Colombo AA; Marchioni E; Diamanti L; Di Matteo AM; Baldanti F; Furione M; Cazzola M; Ferretti VV; Pascutto C; Alessandrino EP
Transplantation; 2017 Mar; 101(3):616-623. PubMed ID: 27222935
[TBL] [Abstract][Full Text] [Related]
29. Gastrointestinal Toxicity, Systemic Inflammation, and Liver Biochemistry in Allogeneic Hematopoietic Stem Cell Transplantation.
Jordan K; Pontoppidan P; Uhlving HH; Kielsen K; Burrin DG; Weischendorff S; Christensen IJ; Jørgensen MH; Heilmann C; Sengeløv H; Müller K
Biol Blood Marrow Transplant; 2017 Jul; 23(7):1170-1176. PubMed ID: 28344059
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus (EBV) load in cerebrospinal fluid and peripheral blood of patients with EBV-associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation.
Liu QF; Ling YW; Fan ZP; Jiang QL; Sun J; Wu XL; Zhao J; Wei Q; Zhang Y; Yu GP; Wu MQ; Feng R
Transpl Infect Dis; 2013 Aug; 15(4):379-92. PubMed ID: 23692640
[TBL] [Abstract][Full Text] [Related]
31. Primary prophylaxis of invasive fungal diseases in allogeneic stem cell transplantation: revised recommendations from a consensus process by Gruppo Italiano Trapianto Midollo Osseo (GITMO).
Girmenia C; Barosi G; Piciocchi A; Arcese W; Aversa F; Bacigalupo A; Bandini G; Bosi A; Busca A; Castagnola E; Caselli D; Cesaro S; Ciceri F; Locasciulli A; Locatelli F; Mikulska M; Pagano L; Prete A; Raiola AM; Rambaldi A
Biol Blood Marrow Transplant; 2014 Aug; 20(8):1080-8. PubMed ID: 24582783
[TBL] [Abstract][Full Text] [Related]
32. Idiopathic inflammatory demyelinating diseases of the central nervous system in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors and survival.
Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Fu HX; Wang M
Chin Med J (Engl); 2013 Mar; 126(6):1096-102. PubMed ID: 23506585
[TBL] [Abstract][Full Text] [Related]
33. Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis.
Montesinos P; Rodríguez-Veiga R; Boluda B; Martínez-Cuadrón D; Cano I; Lancharro A; Sanz J; Arilla MJ; López-Chuliá F; Navarro I; Lorenzo I; Salavert M; Pemán J; Calvillo P; Martínez J; Carpio N; Jarque I; Sanz GF; Sanz MA
Bone Marrow Transplant; 2015 Nov; 50(11):1465-72. PubMed ID: 26281032
[TBL] [Abstract][Full Text] [Related]
34. Recipient and donor PTX3 rs2305619 polymorphisms increase the susceptibility to invasive fungal disease following haploidentical stem cell transplantation: a prospective study.
Zhao C; Zhao XS; Xu LP; Zhang XH; Huang XJ; Sun YQ
BMC Infect Dis; 2022 Mar; 22(1):292. PubMed ID: 35346077
[TBL] [Abstract][Full Text] [Related]
35. Predictive value of circulating angiopoietin-2 for endothelial damage-related complications in allogeneic hematopoietic stem cell transplantation.
Ueda N; Chihara D; Kohno A; Tatekawa S; Ozeki K; Watamoto K; Morishita Y
Biol Blood Marrow Transplant; 2014 Sep; 20(9):1335-40. PubMed ID: 24796281
[TBL] [Abstract][Full Text] [Related]
36. Analysis of donor and recipient ABO incompatibility and antibody-associated complications after allogeneic stem cell transplantation with reduced-intensity conditioning.
Watz E; Remberger M; Ringden O; Lundahl J; Ljungman P; Mattsson J; Wikman A; Uhlin M
Biol Blood Marrow Transplant; 2014 Feb; 20(2):264-71. PubMed ID: 24274982
[TBL] [Abstract][Full Text] [Related]
37. Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation.
Liu YC; Chien SH; Fan NW; Hu MH; Gau JP; Liu CJ; Yu YB; Liu CY; Hsiao LT; Liu JH; Chiou TJ; Chen PM; Tzeng CH
J Microbiol Immunol Infect; 2016 Aug; 49(4):567-74. PubMed ID: 25735797
[TBL] [Abstract][Full Text] [Related]
38. Surgical resection for persistent localized pulmonary fungal infection prior to allogeneic hematopoietic stem cell transplantation: Analysis of six cases.
Harada N; Kimura SI; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Ugai T; Kusuda M; Kameda K; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kako S; Tsubochi H; Kanda Y
J Infect Chemother; 2020 Feb; 26(2):175-180. PubMed ID: 31735628
[TBL] [Abstract][Full Text] [Related]
39. Central nervous system infection following allogeneic hematopoietic stem cell transplantation.
Hanajiri R; Kobayashi T; Yoshioka K; Watanabe D; Watakabe K; Murata Y; Hagino T; Seno Y; Najima Y; Igarashi A; Doki N; Kakihana K; Sakamaki H; Ohashi K
Hematol Oncol Stem Cell Ther; 2017 Mar; 10(1):22-28. PubMed ID: 27664550
[TBL] [Abstract][Full Text] [Related]
40. Gut decontamination during allogeneic hematopoietic stem cell transplantation and the risk of acute graft-versus-host disease.
Gjærde LK; Schmidt M; Sengeløv H
Bone Marrow Transplant; 2018 Aug; 53(8):1061-1064. PubMed ID: 29491465
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
